Results 181 to 190 of about 11,965 (231)

TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review. [PDF]

Circ Cardiovasc Interv
Tartaglia F, Antonelli G, Gitto M, Stankowski K, Donia D, Stefanini G, Latib A, Colombo A, Mangieri A, Chiarito M.   +9 more
europepmc   +1 more source

Understanding Morphologic Right Ventricular Anatomy Facilitates Transcatheter Valve-in-Valve Implantation in Corrected Transposition of Great Arteries. [PDF]

JACC Case Rep
Sagar P, Sivakumar K.
europepmc   +1 more source

Transcatheter Valve-In-Valve Implantation in Patients With Fluoroscopically Invisible Tricuspid Valve Prostheses. [PDF]

JACC Case Rep
Farandzha D, Stoyanov N, Velchev V.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bioprosthesis in hand surgery

Journal of Surgical Research, 1986
In 1965, Carpentier coined the term bioprosthesis to distinguish the characteristics of glutaraldehyde-treated porcine heart valves from untreated or synthetic valves. Observation that the valves functioned normally but were not incorporated by the host has stimulated interest in similarly preserved materials for use in hand surgery.
D J, Smith, C S, Jones, M, Hull, M C, Robson, H E, Kleinert   +4 more
openaire   +2 more sources

Hemodynamic features of the freestyle aortic bioprosthesis compared with stented bioprosthesis

The Annals of Thoracic Surgery, 1998
The Freestyle prosthesis is a new stentless aortic bioprosthesis. Anticipated benefits are improved hemodynamics and increased longevity.Doppler echocardiograms were performed early and at 3 to 6 months, 1 year, and 2 years after operation in 157 patients (69 men, 88 women, aged 48 to 85 years) with this prosthesis, and results were compared with ...
J G, Dumesnil, M H, LeBlanc, P C, Cartier, J, Métras, D, Desaulniers, D P, Doyle, M D, Lemieux, G, Raymond   +7 more
openaire   +2 more sources

Repositionable self-expanding aortic bioprosthesis

Expert Review of Medical Devices, 2017
Transcatheter aortic valve implantation/replacement (TAVI or TAVR) has been established as a first line therapy in patients with symptomatic severe aortic stenosis (AS) at high or prohibitive surgical risk and as an alternative in elderly patients with intermediate surgical risk.
Bruna Gomes, Hugo A. Katus, Raffi Bekeredjian   +2 more
openaire   +2 more sources

Thromboembolism with low profile bioprosthesis

European Heart Journal, 1984
Low profile bioprosthesis late follow-up indicates a low incidence of thromboembolism. For the entire series of 415 consecutively operated patients (rigid and flexible stents) the actuarial probability of freedom at 6 years is 90.3% (87.8% for MVR and 92.27% for AVR and 95.24% for MVR + AVR).
J A, Navia, C, Gimenez, I, Meletti, D, Liotta   +3 more
openaire   +2 more sources

Balloon valvoplasty of mitral bioprosthesis

International Journal of Cardiology, 1991
We describe a case of percutaneous balloon valvoplasty of a stenotic Ionescu-Shiley mitral bioprosthesis with the help of an original emboli-protecting device. The procedure reduced diastolic gradient from 29 to 9 mmHg. The calculated area of the orifice increased from 0.7 to 1.7 cm2.
U U, Babic, S, Grujicic, M, Vucinic
openaire   +2 more sources

Conduit-on-valve replacement of a degenerated mitral bioprosthesis with a bioprosthesis

The Annals of Thoracic Surgery, 2003
Explantation of a degenerated mitral bioprosthesis with reimplantation of a new bioprosthesis is time-consuming and can be associated with several life-threatening complications. We developed a technique to simplify this procedure and avoid the complications by attaching a new bioprosthesis supported by a pericardium-covered Dacron tube to the intact ...
Jen-Ping, Chang, Chiung-Lun, Kao, Kuei-Ton, Tsai, Ming-Jang, Hsieh, Morgan, Fu   +4 more
openaire   +2 more sources